Eli Lilly Dan Skovronsky discusses weight loss drugs
Dan Skovronsky knows what a good drug of obesity does. As head of scientific officer in Eli LillyHe has already…
amgen inc
Eli Lilly and Amazon announce agreements at JPMorgan conference
A version of this article first appeared in CNBC's Healthy Returns newsletter, bringing the latest healthcare news directly to your…
Eli Lilly's lead in the obesity race has increased. Its recent stock performance says otherwise.
Eli Lilly investors have received some very good news in recent months, with one notable exception regarding the stock's performance.…
FDA approvals fall in 2024, Transcarent acquires Accolade
Signs are seen outside the Food and Drug Administration (FDA) headquarters in White Oak, Maryland, on August 29, 2020. Andrew…
Wall Street mulls data on weight-loss drug Amgen
The Amgen logo is displayed outside of Amgen headquarters in Thousand Oaks, California, on May 17, 2023. Mario Tama |…
Amgen says anti-obesity drug MariTide caused up to 20% weight loss after one year
The Amgen logo is displayed outside of Amgen headquarters in Thousand Oaks, California, on May 17, 2023. Mario Tama |…
Eli Lilly's cholesterol pill impresses in trial
A version of this article first appeared in CNBC's Healthy Returns newsletter, bringing the latest healthcare news directly to your…
Amgen Stock Falls on Weight Loss Drug's Bone Density Loss Data
Omar Marqués | Light rocket | fake images Actions of amgen fell more than 7% on Tuesday as analysts analyzed…
Medicare publishes prices for the first 10 drugs subject to negotiations
Activists protest prescription drug prices in front of the U.S. Department of Health and Human Services building in Washington, DC,…
What Wall Street is watching
Investors want to know if Eli Lilly is experiencing the same pricing pressures on its blockbuster weight-loss drug Zepbound that…